The Biometry Core has two closely coupled principal components, the Research Database Management Section and the Biostatistics Section. The Research Database Management Section will serve the Center's """"""""core"""""""" database and almost all of the individual projects, providing the following types of services: assistance in the design of effective data collection instruments and protocols; design, implementation, and operation of efficient database management systems for processing research data, including effective subsystems for error detection/correction, data storage, data quality assurance, security (protection against data loss or corruption), protection of confidentiality, data retrieval, generation of routine reports, generation of special reports, and generation of """"""""analysis files"""""""": files structured for direct use by statistical analysis software. The Biostatistics Section will provide the Center's projects with assistance in the design of studies (clinical, epidemiological, and laboratory), assistance in the preparation of research protocols, assistance in monitoring study execution and data collection, and collaboration statistical analyses and writing research reports and papers. The Biometry Core (including both sections) has been in operation under Dr. Helms' direction (as a component of a UNC SCOR project, not related to the Sickle Cell Center) for more than 10 years. Drs. Stewart and Burchinal have been full Core participants for 9 and 5 years, respectively. The core is a smoothly functioning unit with well- developed operational procedures and highly productive computer facilities.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL028391-14
Application #
5213391
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1996
Total Cost
Indirect Cost
Ariens, Robert A S; Lai, Thung-Shenq; Weisel, John W et al. (2002) Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100:743-54
Ware, Russell E; Eggleston, Barry; Redding-Lallinger, Rupa et al. (2002) Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood 99:10-4
Thompson Jr, Robert J; Gustafson, Kathryn E; Bonner, Melanie J et al. (2002) Neurocognitive development of young children with sickle cell disease through three years of age. J Pediatr Psychol 27:235-44
Slaughter, T F; Sreeram, G; Sharma, A D et al. (2001) Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer. Blood Coagul Fibrinolysis 12:85-93
Lai, T S; Hausladen, A; Slaughter, T F et al. (2001) Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. Biochemistry 40:4904-10
Ataga, K I; Orringer, E P (2000) Renal abnormalities in sickle cell disease. Am J Hematol 63:205-11
Ataga, K I; Orringer, E P (2000) Bone marrow necrosis in sickle cell disease: a description of three cases and a review of the literature. Am J Med Sci 320:342-7
Kinney, T R; Helms, R W; O'Branski, E E et al. (1999) Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood 94:1550-4
Lai, T S; Slaughter, T F; Peoples, K A et al. (1999) Site-directed mutagenesis of the calcium-binding site of blood coagulation factor XIIIa. J Biol Chem 274:24953-8
Slentz-Kesler, K A; Hale, L P; Kaufman, R E (1998) Identification and characterization of K12 (SECTM1), a novel human gene that encodes a Golgi-associated protein with transmembrane and secreted isoforms. Genomics 47:327-40

Showing the most recent 10 out of 78 publications